MIDODRINE HCL- midodrine hydrochloride tablet

Country: Ամերիկայի Միացյալ Նահանգներ

language: անգլերեն

source: NLM (National Library of Medicine)

active_ingredient:

MIDODRINE HYDROCHLORIDE (UNII: 59JV96YTXV) (MIDODRINE - UNII:6YE7PBM15H)

MAH:

American Health Packaging

INN:

MIDODRINE HYDROCHLORIDE

composition:

MIDODRINE HYDROCHLORIDE 2.5 mg

administration_route:

ORAL

prescription_type:

PRESCRIPTION DRUG

therapeutic_indication:

Midodrine hydrochloride tablets, USP are indicated for the treatment of symptomatic orthostatic hypotension (OH). Because midodrine hydrochloride tablets, USP can cause marked elevation of supine blood pressure (BP > 200 mmHg systolic), it should be used in patients whose lives are considerably impaired despite standard clinical care, including non-pharmacologic treatment (such as support stockings), fluid expansion and lifestyle alterations. The indication is based on midodrine hydrochloride tablet, USP's effect on increases in 1-minute standing systolic blood pressure, a surrogate marker considered likely to correspond to a clinical benefit. At present, however, clinical benefits of midodrine hydrochloride tablets, USP principally improved ability to perform life activities, have not been established. Further clinical trials are underway to verify and describe the clinical benefits of midodrine hydrochloride tablets, USP. After initiation of treatment, midodrine hydrochloride tablets, USP should be continue

leaflet_short:

Midodrine Hydrochloride Tablets, USP, for oral administration, are available as 2.5 mg White, round, flat-faced, bevelled edge, debossed “ E ” over “40” on one side and bisected on the other side and supplied as: Unit dose packages of 100 (10 x 10) NDC 68084-240-01 5 mg Reddish-orange, round, flat-faced, bevelled edge, debossed “ E ” over “43” on one side and bisected on the other side and supplied as: Unit dose packages of 100 (10 x 10) NDC 68084-241-01 Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Protect from light and moisture. FOR YOUR PROTECTION: Do not use if blister is torn or broken. To report SUSPECTED ADVERSE REACTIONS, contact Sandoz Inc. at 1-800-525-8747 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

authorization_status:

Abbreviated New Drug Application

SPC

MIDODRINE HCL- MIDODRINE HYDROCHLORIDE TABLET
AMERICAN HEALTH PACKAGING
----------
MIDODRINE HYDROCHLORIDE TABLETS, USP
8024001/1017
RX ONLY
WARNING
BECAUSE MIDODRINE HYDROCHLORIDE TABLETS CAN CAUSE MARKED ELEVATION OF
SUPINE BLOOD
PRESSURE, IT SHOULD BE USED IN PATIENTS WHOSE LIVES ARE CONSIDERABLY
IMPAIRED DESPITE
STANDARD CLINICAL CARE. THE INDICATION FOR USE OF MIDODRINE
HYDROCHLORIDE TABLETS IN THE
TREATMENT OF SYMPTOMATIC ORTHOSTATIC HYPOTENSION IS BASED PRIMARILY ON
A CHANGE IN A
SURROGATE MARKER OF EFFECTIVENESS, AN INCREASE IN SYSTOLIC BLOOD
PRESSURE MEASURED ONE
MINUTE AFTER STANDING, A SURROGATE MARKER CONSIDERED LIKELY TO
CORRESPOND TO A CLINICAL
BENEFIT. AT PRESENT, HOWEVER, CLINICAL BENEFITS OF MIDODRINE
HYDROCHLORIDE TABLETS,
PRINCIPALLY IMPROVED ABILITY TO CARRY OUT ACTIVITIES OF DAILY LIVING,
HAVE NOT BEEN VERIFIED.
DESCRIPTION
Midodrine hydrochloride is a vasopressor/antihypotensive agent.
Midodrine hydrochloride is an
odorless, white, crystalline powder, soluble in water and sparingly
soluble in methanol having a pKa of
7.8 (0.3% aqueous solution), a pH of 3.5 to 5.5 (5% aqueous solution)
and a melting range of 200°C to
203°C. It is chemically described as: (1) Acetamide, 2-amino-
_N_-[2-(2,5-dimethoxyphenyl)-2-
hydroxyethyl]-monohydrochloride, (±)-; or (2) (±)-2-amino-
_N_-(ß-hydroxy-2,5-
dimethoxyphenethyl)acetamide monohydrochloride. Midodrine
hydrochloride’s molecular formula is C
H
N
O
HCl, its molecular weight is 290.7 and its structural formula is:
Each tablet for oral administration contains 2.5 mg, 5 mg or 10 mg of
midodrine hydrochloride and the
following inactive ingredients: pregelatinized starch (corn starch),
microcrystalline cellulose, colloidal
silicon dioxide, magnesium stearate. In addition, the 5 mg tablets
contain FD&C yellow No. 6 aluminum
lake and FD&C red No. 40 aluminum lake and the 10 mg tablets contain
FD&C blue No. 2 aluminum
lake.
CLINICAL PHARMACOLOGY
12
18
2
4
MECHANISM OF ACTION
Midodrine hydrochloride forms an active metabolite, desglymidodrine,
that is an